Roswell Biotechnologies

About Roswell Biotechnologies

Roswell Biotechnologies is at the forefront of revolutionizing genome sequencing and precision medicine through the innovative use of molecular electronics. The company operates in the biotechnology sector, focusing on integrating single molecules into electrical circuits to create nanoscale circuit elements. This technology significantly reduces the time required for whole genome sequencing from days to minutes, making it more accessible and cost-effective. Roswell's solutions span various applications, including agriculture and pathogen detection, providing comprehensive tools for diverse biomarker identification. The company serves clients in the healthcare, agricultural, and research sectors, aiming to democratize access to precision medicine. Roswell Biotechnologies generates revenue through the sale of its advanced sequencing technologies and related services, leveraging scalable sequencing chemistry and nanotechnology to meet the growing demand for DNA reading. The business model is centered on continuous innovation and interdisciplinary collaboration, supported by a team of experts and advisors, including renowned geneticist Dr. George Church. By delivering greater accuracy than current next-generation sequencing (NGS) technologies, Roswell is poised to drive the sequencing revolution forward, making precision medicine more equitable and accessible.